Latest PTEN Stories
Genetic mutations aren’t the only thing that can keep a protein called PTEN from doing its tumor-suppressing job.
A novel gene variant found in human and animal tissue may be a promising treatment for cancer, including breast and brain cancer, according to scientists from the Icahn School of Medicine at Mount
Researchers from the Masonic Cancer Center, University of Minnesota, and the University’s Brain Tumor Program, have developed a new mouse model of malignant peripheral nerve sheath tumors (MPNST) that allow them to discover new genes and gene pathways driving this type of cancer.
Researchers at Karolinska Institutet in Sweden have identified a new so-called pseudogene that regulates the tumor-suppressing PTEN gene.
Small stretches of DNA in the human genome are known as "pseudogenes" because, while their sequences are nearly identical to those of various genes, they have long been thought to be non-coding "junk" DNA.
Scientists from the University of Texas Medical Branch at Galveston and the University of Houston found a new way to influence the vital serotonin signaling system. The team linked malfunctions in serotonin signaling to a range of health issues, including everything from depression and addictions, to epilepsy and obesity.
The combined loss of two tumor suppressor genes was shown to be strongly associated with progression of DCIS to invasive breast cancer.
Scientists have found that a chemical can help start the change of eggs from small to mature, which could provide increased opportunities for women to undergo IVF treatment in the future.
Scientists affiliated with the UC Davis MIND Institute have discovered how a defective gene causes brain changes that lead to the atypical social behavior characteristic of autism.
Melanoma – the deadliest and most aggressive form of skin cancer – has long been linked to time spent in the sun.
- A member of the swell-mob; a genteelly clad pickpocket. Sometimes mobsman.